Publicaciones (38) Publicaciones de JORGE ORTEGA CALVO

2023

  1. Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 348-365

  2. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

    Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350

  3. Psilozibinaren administrazio akutuaren eraginen ebaluazioa garun kortexean serotonina, noradrenalina eta dopamina mailak neurtuz: garun-mikrodialisiaren bidez burututako ikerlana esna dauden saguetan

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

2022

  1. Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. Europar Batasunean merkaturatutako SARS-CoV-2 birusaren aurkako txertoen onura/arrisku orekaren ebaluazioa

    Osagaiz: osasun-zientzien aldizkaria, Vol. 5, Núm. 2, pp. 77-96

  2. In Vivo Brain Microdialysis of Monoamines

    Neuromethods (Humana Press Inc.), pp. 489-512

  3. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways

    Frontiers in Pharmacology, Vol. 12

2020

  1. Terapia antidepresiboaren azken pausoak: oraina eta geroa

    Osagaiz: osasun-zientzien aldizkaria, Vol. 4, Núm. 2, pp. 21-36

2019

  1. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus

    Neuropharmacology, Vol. 158

  2. Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 3038-3052

2018

  1. Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram

    Neuropharmacology, Vol. 133, pp. 491-502

  2. Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions

    Neuropsychopharmacology, Vol. 43, Núm. 5, pp. 1041-1051

2017

  1. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain

    Neuropharmacology, Vol. 114, pp. 114

  2. Insomnioaren tratamendu fitoterapeutikoa

    Osagaiz: osasun-zientzien aldizkaria, Vol. 1, Núm. 2, pp. 65-68

2016

  1. Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study

    Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867

  2. In vivo brain microdialysis of monoamines

    Neuromethods (Humana Press Inc.), pp. 415-434

2015

  1. Erratum: α2-adrenoceptor antagonists: Synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives (Journal of Medicinal Chemistry (2015) 58 (963-977) DOI: 10.1021/jm501635e)

    Journal of Medicinal Chemistry

  2. α2-adrenoceptor antagonists: Synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives

    Journal of Medicinal Chemistry, Vol. 58, Núm. 2, pp. 963-977

2014

  1. Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain

    Journal of Neuroinflammation, Vol. 11, Núm. 1

2013

  1. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain

    European Journal of Pharmacology, Vol. 709, Núm. 1-3, pp. 13-19